1 / 11

Introduction to H IV Vaccines

Introduction to H IV Vaccines. Definition. A vaccine is a substance that teaches the body’s immune system to recognize and protect against a disease caused by an infectious agent. A vaccine primer. 200 years of vaccines Common vaccines Types of immunity: humoral (antibody) and cell-mediated

dena
Télécharger la présentation

Introduction to H IV Vaccines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Introduction to HIV Vaccines International HIV/AIDS Toolkit

  2. Definition • A vaccine is a substance that teaches the body’s immune system to recognize and protect against a disease caused by an infectious agent. International HIV/AIDS Toolkit

  3. A vaccine primer • 200 years of vaccines • Common vaccines • Types of immunity: humoral (antibody) and cell-mediated • An ideal HIV vaccine • Preventative or therapeutic? • Vaccine development stages International HIV/AIDS Toolkit

  4. State of Vaccine Research • First trial in 1987 • 30 products tested • 60 clinical trials • 2 phase III trials • 1% of global health R&D • In Canada, only AIDSVAX trial • $2.14 million in Canada on research International HIV/AIDS Toolkit

  5. State of Canadian vaccine research • CANVAC • CIHR • CIDA grant to IAVI • Globally: a few pharmas, universities and governments • A narrow pipeline! International HIV/AIDS Toolkit

  6. Impact on the epidemic Low-efficacy: • Delivered to « high-risk » population • Level of awareness of vaccines • Level of trust of vaccines • Attitudes towards HIV/AIDS • Stigma & discrimination International HIV/AIDS Toolkit

  7. Impact on the epidemic Low-efficacy (2) • Rates of coverage • Vaccine optimism • Combination prevention High efficacy • Very similar issues! No efficacy BUT still OK! International HIV/AIDS Toolkit

  8. Who’s Who • International AIDS Vaccine Initiative (IAVI) • Canadian AIDS Society (CAS) • Canadian HIV/AIDS Legal Network • Canadian Network for Vaccines and Immunotherapeutics (CANVAC) International HIV/AIDS Toolkit

  9. Canadian HIV Vaccines Plan • 1) Ensuring Canada’s commitment to the development of HIV vaccines • 2) Ensuring public engagement • 3) Ensuring integrated strategic plans for HIV vaccine research and development • 4) Ensuring equitable vaccine access and delivery International HIV/AIDS Toolkit

  10. Becoming involved • Getting and disseminating information • Subscribing to IAVI Report or VAX • Advocating for vaccine development • Raising information in your community • Participating in development of Canadian HIV Vaccines Plan International HIV/AIDS Toolkit

  11. Sources of Information • www.iavi.org IAVI Report, VAX • www.avac.org Handbook, reports • www.cdnaids.ca Basics, advocacy updates • www.aidslaw.ca Discussion paper, info sheets • www.icaso.org Primers • www.canvacc.org Vaccines, R&D International HIV/AIDS Toolkit

More Related